India approves first dengue vaccine QDENGA for people aged 4-60 years

IANS | July 20, 2026 2:24 PM

New Delhi, July 20 (IANS) India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to Takeda Biopharmaceuticals India's QDENGA, marking a significant milestone in the country's efforts to combat one of its most widespread mosquito-borne diseases, it was announced on Monday.

ICMR drone project reduces TB diagnosis time, eases patient burden

IANS | July 16, 2026 11:46 AM

New Delhi, July 16 (IANS) The Indian Council of Medical Research’s flagship i-DRONE initiative demonstrated that drone‑assisted transport of TB sputum samples improved access to diagnostic services for people living in remote and underserved areas in the Yadadri‑Bhuvanagiri district, Telangana, the government said on Thursday.

India-origin pharma patents jump four-fold, innovation pipeline tops 1,095: Report

IANS | July 15, 2026 11:34 AM

New Delhi, July 15 (IANS) India-origin pharmaceutical patent families have risen more than four-fold over the past decade, while the country's drug discovery pipeline has expanded to more than 1,095 programmes across 195 companies, signalling a rapid shift from generics-led manufacturing to innovation-driven research, a report showed on Wednesday.